NDC 15631-0179

EQUISETUM HYEMALE

Equisetum Hyemale

EQUISETUM HYEMALE is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Equisetum Hyemale.

Product ID15631-0179_a11ad69a-199f-78e9-e053-2a95a90a8b84
NDC15631-0179
Product TypeHuman Otc Drug
Proprietary NameEQUISETUM HYEMALE
Generic NameEquisetum Hyemale
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameEQUISETUM HYEMALE
Active Ingredient Strength3 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0179-0

100 PELLET in 1 PACKAGE (15631-0179-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0179-2 [15631017902]

EQUISETUM HYEMALE PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0179-4 [15631017904]

EQUISETUM HYEMALE PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0179-3 [15631017903]

EQUISETUM HYEMALE PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0179-1 [15631017901]

EQUISETUM HYEMALE PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0179-5 [15631017905]

EQUISETUM HYEMALE PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0179-0 [15631017900]

EQUISETUM HYEMALE PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

Drug Details

Active Ingredients

IngredientStrength
EQUISETUM HYEMALE3 [hp_X]/1

OpenFDA Data

SPL SET ID:0ed17479-a422-4b45-8314-edf8d4c7b061
Manufacturer
UNII

NDC Crossover Matching brand name "EQUISETUM HYEMALE" or generic name "Equisetum Hyemale"

NDCBrand NameGeneric Name
0220-1885Equisetum hyemaleEQUISETUM HYEMALE
0220-1886Equisetum hyemaleEQUISETUM HYEMALE
0220-1889Equisetum hyemaleEQUISETUM HYEMALE
0220-1890Equisetum hyemaleEQUISETUM HYEMALE
0220-1896Equisetum hyemaleEQUISETUM HYEMALE
15631-0179EQUISETUM HYEMALEEQUISETUM HYEMALE
15631-0578EQUISETUM HYEMALEEQUISETUM HYEMALE
37662-0673Equisetum HyemaleEquisetum Hyemale
37662-0674Equisetum HyemaleEquisetum Hyemale
37662-0675Equisetum HyemaleEquisetum Hyemale
37662-0676Equisetum HyemaleEquisetum Hyemale
37662-0677Equisetum HyemaleEquisetum Hyemale
37662-0678Equisetum HyemaleEquisetum Hyemale
37662-0679Equisetum HyemaleEquisetum Hyemale
37662-0680Equisetum HyemaleEquisetum Hyemale
68428-368Equisetum hyemaleEQUISETUM HYEMALE
71919-269Equisetum hyemaleEQUISETUM HYEMALE
64117-142IncontinenceEQUISETUM HYEMALE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.